Allergy Therapeutics PLC
XBER:HHU
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Allergy Therapeutics PLC
XBER:HHU
|
UK |
|
C
|
Cerrado Gold Corp
OTC:CRDOF
|
CA |
|
Dynavax Technologies Corp
LSE:0IDA
|
US |
|
Bangkok Dusit Medical Services PCL
OTC:BDUUY
|
TH |
|
M
|
Mohawk Industries Inc
LSE:0K2F
|
US |
|
Critical Elements Lithium Corp
OTC:CRECF
|
CA |
|
V
|
Veritone Inc
SWB:VEK
|
US |
|
C
|
CMS Energy Corp
XBER:CSG
|
US |
|
P
|
Precigen Inc
F:I5X
|
US |
|
Alithya Group Inc
F:0QZ
|
CA |
|
N
|
NIB Holdings Ltd
F:3GU
|
AU |
|
T
|
Toho Co Ltd (Tokyo)
DUS:TOH
|
JP |
|
R
|
Renovaro Biosciences Inc
NASDAQ:RENB
|
US |
|
R
|
Rexel SA
XMUN:E7V
|
FR |
Wall St Price Targets
HHU Price Targets Summary
Allergy Therapeutics PLC
According to Wall Street analysts, the average 1-year price target for
HHU is 0.173 EUR with a low forecast of 0.171 EUR and a high forecast of 0.178 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is HHU's stock price target?
Price Target
0.173
EUR
According to Wall Street analysts, the average 1-year price target for
HHU is 0.173 EUR with a low forecast of 0.171 EUR and a high forecast of 0.178 EUR.
What is the Revenue forecast for Allergy Therapeutics PLC?
Projected CAGR
18%
Over the last 13 years, the compound annual growth rate for Revenue has been 2%. The projected CAGR for the next 1 year is 18%.